Unveiling HERV‐K113‐ENV as SARS‐CoV‐2 severity admissible biomarker by mining transcriptome data

alexandrossfakianakis shared this article with you from Inoreader Unveiling HERV‐K113‐ENV as SARS‐CoV‐2 severity admissible biomarker by mining transcriptome data via Journal of Medical Virology Abstract Discovering the severity biomarker for SASR-CoV-2 can reduce the unnecessary hospital occupancy of COVID-19-positive adult people. Here we report the human endogenous retrovirus K113 envelope (HERV-K113-ENV) transcription as an admissible SARS-CoV-2 severity biomarker by the mining of adult Indian whole-blood transcriptome data. This article is protected by copyright. All rights reserved. View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.